Suvaxyn Parvo/E-Amphigen inj. emuls. i.m. vial

Country: Բելգիա

language: անգլերեն

source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

active_ingredient:

Porcine Parvovirus ; Erysipelothrix rhusiopathiae (inactivated)

MAH:

Zoetis Belgium SA-NV

ATC_code:

QI09AL01

INN:

Porcine Parvovirus; Erysipelothrix Rhusiopathiae, Inactivated

pharmaceutical_form:

Emulsion for injection

composition:

Porcine Parvovirus; Erysipelothrix Rhusiopathiae, Inactivated

administration_route:

Intramuscular use

therapeutic_group:

pig

therapeutic_area:

Porcine Parvovirus + Erysipelothrix

leaflet_short:

CTI code: 506631-02 - Pack size: 25 doses (50 (50) - Commercialisation status: NO - FMD code: 05414736036175 - CNK code: 3631124 - Delivery mode: Medical prescription; CTI code: 506631-01 - Pack size: 10 doses (20 (20) - Commercialisation status: NO - Delivery mode: Medical prescription

authorization_status:

Commercialised: No

authorization_date:

2017-02-22